STRATEC Biomedical AG Approves Distribution of Dividend for the Year 2016, Payable on June 20, 2017; Announces Board Changes
Shareholders approved the actions of the Board of Management and the Supervisory Board and elected Roland Baule (68), Managing Director of Baule GmbH and former CEO of Fresenius Kabi AG, to the Supervisory Board. He will succeed Wolfgang Wehmeyer, who retired from the Supervisory Board at his own request upon the conclusion of the Annual General Meeting. STRATEC's Board of Management and Supervisory Board would like to take this opportunity to thank Mr. Wehmeyer for the good and close working relationship over the years.